Your browser doesn't support javascript.
loading
Inferring causal genes at type 2 diabetes GWAS loci through chromosome interactions in islet cells.
Torres, Jason M; Sun, Han; Nylander, Vibe; Downes, Damien J; van de Bunt, Martijn; McCarthy, Mark I; Hughes, Jim R; Gloyn, Anna L.
Afiliação
  • Torres JM; Wellcome Centre for Human Genetics, University of Oxford, Oxford, England, OX3 7BN, UK.
  • Sun H; Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Nylander V; Oxford Centre for Diabetes Endocrinology & Metabolism, University of Oxford, Oxford, England, OX3 7L3, UK.
  • Downes DJ; Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9D2, UK.
  • van de Bunt M; Wellcome Centre for Human Genetics, University of Oxford, Oxford, England, OX3 7BN, UK.
  • McCarthy MI; Oxford Centre for Diabetes Endocrinology & Metabolism, University of Oxford, Oxford, England, OX3 7L3, UK.
  • Hughes JR; Present address: Cytoki Pharma ApS, Tuborg Boulevard 12, Hellerup, DK-2900, Denmark.
  • Gloyn AL; Wellcome Centre for Human Genetics, University of Oxford, Oxford, England, OX3 7BN, UK.
Wellcome Open Res ; 8: 165, 2023.
Article em En | MEDLINE | ID: mdl-37736013
Background: Resolving causal genes for type 2 diabetes at loci implicated by genome-wide association studies (GWAS) requires integrating functional genomic data from relevant cell types. Chromatin features in endocrine cells of the pancreatic islet are particularly informative and recent studies leveraging chromosome conformation capture (3C) with Hi-C based methods have elucidated regulatory mechanisms in human islets. However, these genome-wide approaches are less sensitive and afford lower resolution than methods that target specific loci. Methods: To gauge the extent to which targeted 3C further resolves chromatin-mediated regulatory mechanisms at GWAS loci, we generated interaction profiles at 23 loci using next-generation (NG) capture-C in a human beta cell model (EndoC-ßH1) and contrasted these maps with Hi-C maps in EndoC-ßH1 cells and human islets and a promoter capture Hi-C map in human islets. Results: We found improvements in assay sensitivity of up to 33-fold and resolved ~3.6X more chromatin interactions. At a subset of 18 loci with 25 co-localised GWAS and eQTL signals, NG Capture-C interactions implicated effector transcripts at five additional genetic signals relative to promoter capture Hi-C through physical contact with gene promoters. Conclusions: High resolution chromatin interaction profiles at selectively targeted loci can complement genome- and promoter-wide maps.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article